Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-254589 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 3, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
25,306
Total Value
$26,318.24
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jun 2, 2026 | Exercise/Conversion | 12,653 | $2.08 | $26,318.24 | 260,241 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Jun 2, 2026 | Exercise/Conversion | 12,653 | $0.00 | $0.00 | 0 | Direct | โ | View Details |